BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37123609)

  • 1. Case Report: Evolutionary Clinical-Radiological Features of a Diffuse Hemispheric Glioma, H3 G34 Mutant with Over 5 Years of Survival.
    Yamada CAF; Soldatelli MD; do Amaral LLF; Campos CMS; de Moraes PL; Chaddad-Neto FEA; Lancellotti CLP
    Case Rep Oncol; 2023; 16(1):279-286. PubMed ID: 37123609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High frequency of PDGFRA and MUC family gene mutations in diffuse hemispheric glioma, H3 G34-mutant: a glimmer of hope?
    Hu W; Duan H; Zhong S; Zeng J; Mou Y
    J Transl Med; 2022 Feb; 20(1):64. PubMed ID: 35109850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetics to clinicopathological features: a bibliometric analysis of H3 G34-mutant diffuse hemispheric glioma literature.
    Roach JT; Riviere-Cazaux C; Wells BA; Boop FA; Daniels DJ
    Childs Nerv Syst; 2024 Apr; ():. PubMed ID: 38613587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric diffuse hemispheric glioma H3 G34-mutant with gains of the BRAF locus: An illustrative case.
    Marlow C; Cuoco JA; Hoggarth AR; Stump MS; Apfel LS; Rogers CM
    Rare Tumors; 2023; 15():20363613231168704. PubMed ID: 37056711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of diffuse hemispheric gliomas, H3 G34-mutant in adults.
    Picart T; Barritault M; Poncet D; Berner LP; Izquierdo C; Tabouret E; Figarella-Branger D; Idbaïh A; Bielle F; Bourg V; Vandenbos FB; Moyal EC; Uro-Coste E; Guyotat J; Honnorat J; Gabut M; Meyronet D; Ducray F
    Neurooncol Adv; 2021; 3(1):vdab061. PubMed ID: 34056608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI characteristics of H3 G34-mutant diffuse hemispheric gliomas and possible differentiation from IDH-wild-type glioblastomas in adolescents and young adults.
    Shao H; Gong J; Su X; Chen N; Li S; Yang X; Zhang S; Huang Z; Hu W; Gong Q; Liu Y; Yue Q
    J Neurosurg Pediatr; 2024 Mar; 33(3):236-244. PubMed ID: 38157540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review of diffuse hemispheric glioma, H3 G34-mutant: Outcomes and associated clinical factors.
    Crowell C; Mata-Mbemba D; Bennett J; Matheson K; Mackley M; Perreault S; Erker C
    Neurooncol Adv; 2022; 4(1):vdac133. PubMed ID: 36105387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of arterial spin labeling for objective assessment of intratumoral microvessels in diffuse hemispheric glioma, H3 G34R-mutant: A case report and literature review.
    Kitakami K; Beppu T; Sato Y; Kurose A; Ogasawara K
    Radiol Case Rep; 2023 Mar; 18(3):856-861. PubMed ID: 36589502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Midline invasion predicts poor prognosis in diffuse hemispheric glioma, H3 G34-mutant: an individual participant data review.
    Kegoya Y; Otani Y; Inoue Y; Mizuta R; Higaki F; Washio K; Koizumi S; Kurozumi K; Ishida J; Fujii K; Yamamoto N; Tanaka Y; Date I
    J Neurooncol; 2024 Mar; 167(1):201-210. PubMed ID: 38427132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging features associated with H3 K27-altered and H3 G34-mutant gliomas: a narrative systematic review.
    Lasocki A; Abdalla G; Chow G; Thust SC
    Cancer Imaging; 2022 Nov; 22(1):63. PubMed ID: 36397143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. H3 G34-mutant high-grade glioma.
    Lim KY; Won JK; Park CK; Kim SK; Choi SH; Kim T; Yun H; Park SH
    Brain Tumor Pathol; 2021 Jan; 38(1):4-13. PubMed ID: 32995948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. H3 G34-mutant high-grade gliomas: integrated clinical, imaging and pathological characterisation of a single-centre case series.
    Lavrador JP; Reisz Z; Sibtain N; Rajwani K; Baig Mirza A; Vergani F; Gullan R; Bhangoo R; Ashkan K; Bleil C; Zebian B; Clark B; Laxton R; King A; Bodi I; Al-Saraj S
    Acta Neurochir (Wien); 2023 Jun; 165(6):1615-1633. PubMed ID: 36929449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paediatric-type diffuse high-grade gliomas in the 5th CNS WHO Classification.
    Gianno F; Giovannoni I; Cafferata B; Diomedi-Camassei F; Minasi S; Barresi S; Buttarelli FR; Alesi V; Cardoni A; Antonelli M; Puggioni C; Colafati GS; Carai A; Vinci M; Mastronuzzi A; Miele E; Alaggio R; Giangaspero F; Rossi S
    Pathologica; 2022 Dec; 114(6):422-435. PubMed ID: 36534421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroimaging features of diffuse hemispheric glioma, H3 G34-mutant: A case series and systematic review.
    Kurokawa R; Baba A; Kurokawa M; Pinarbasi ES; Makise N; Ota Y; Kim J; Srinivasan A; Moritani T
    J Neuroimaging; 2022 Jan; 32(1):17-27. PubMed ID: 34632671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiological and Immunostaining Characteristics of H3.3 G34R-Mutant Glioma: A Report of 3 Cases and Review of the Literature.
    Onishi S; Amatya VJ; Karlowee V; Takeshima Y; Sugiyama K; Kurisu K; Yamasaki F
    Pediatr Neurosurg; 2020; 55(5):319-325. PubMed ID: 33227796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffuse hemispheric glioma with H3-3B G34R mutation: Expanding the spectrum of histone H3 genes in diffuse hemispheric glioma, H3 G34-mutant.
    Nazem A; Lavezo J; Abdullaev Z; Aldape K; Quezado M; Cimino PJ; Pratt DW; Jenkins RB; Ida CM
    J Neuropathol Exp Neurol; 2023 Dec; 83(1):58-60. PubMed ID: 37878797
    [No Abstract]   [Full Text] [Related]  

  • 17. Histologically distinct neuroepithelial tumors with histone 3 G34 mutation are molecularly similar and comprise a single nosologic entity.
    Korshunov A; Capper D; Reuss D; Schrimpf D; Ryzhova M; Hovestadt V; Sturm D; Meyer J; Jones C; Zheludkova O; Kumirova E; Golanov A; Kool M; Schüller U; Mittelbronn M; Hasselblatt M; Schittenhelm J; Reifenberger G; Herold-Mende C; Lichter P; von Deimling A; Pfister SM; Jones DT
    Acta Neuropathol; 2016 Jan; 131(1):137-46. PubMed ID: 26482474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Diffuse Gliomas With Histone H3-G34 Mutation by MRI and Dynamic 18F-FET PET.
    Vettermann FJ; Felsberg J; Reifenberger G; Hasselblatt M; Forbrig R; Berding G; la Fougère C; Galldiks N; Schittenhelm J; Weis J; Albert NL; Schüller U
    Clin Nucl Med; 2018 Dec; 43(12):895-898. PubMed ID: 30358620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral hemispheric glioblastoma with PNET-like morphology and histone H3.3 G34 mutation in younger patients: Report of three rare cases and diagnostic pitfalls.
    Cheng Y; Bao W; Wu Q
    Indian J Pathol Microbiol; 2020; 63(2):262-266. PubMed ID: 32317528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic significance of further genotyping H3G34 diffuse hemispheric gliomas.
    Vuong HG; Le HT; Dunn IF
    Cancer; 2022 May; 128(10):1907-1912. PubMed ID: 35195909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.